HubPharm Africa is building the healthcare infrastructure that ensures every African - regardless of location or income - can access genuine, affordable, life-saving medicines and the expert support to use them safely.
"We did not build HubPharm to be just another pharmacy. We built it to be the infrastructure that keeps African patients alive, adherent, and informed." - Sesan Kareem, Founder & President, HubPharm Africa
Every number below represents a patient who got the medicine they needed, a caregiver who wasn't left guessing, and a community brought closer to health equity.
HubPharm Africa started in 2021 with a simple, urgent conviction: too many Nigerians were dying not because cures didn't exist, but because they couldn't reliably access the medicines their doctors prescribed. Counterfeit drugs, broken supply chains, and uncoordinated care were killing patients who should have been living full lives.
We built HubPharm to fix this - not as a transactional pharmacy, but as a chronic care infrastructure company. Every patient who joins our programme receives verified medicines, personalised pharmacist support, Afiya AI check-ins, and a coordinated care plan that keeps them on track month after month.
From our base at 17 Ademola Osinowo Street, Ikosi Ketu, Lagos, we have grown from a small specialty pharmacy to a platform reaching 10,200+ chronic care patients, 15K+ Afiya AI users, and communities in 31 countries. This is the mission in action.
Read Our Purpose →HubPharm runs six specialist chronic disease programmes, each with dedicated pharmacists, sourcing protocols, and patient education pathways.
Beyond our pharmacy, HubPharm runs free health screening and medical outreach programmes that have directly touched thousands of lives in underserved communities across Lagos.
HubPharm's inaugural community health screening event brought free blood pressure checks, blood glucose testing, BMI assessments, and pharmacist consultations directly to underserved communities in Lagos. Patients who had never seen a healthcare professional received diagnoses, referrals, and medicine access on the same day.
HubPharm partnered with Shalina Healthcare to run a targeted free health initiative during Ramadan 2025, focusing on peptic ulcer disease - a condition significantly worsened by extended fasting. Community members received free screening, education, and medicines to safely fast during Ramadan without compromising their health.
Building on 2024's success, HubPharm's 2025 Medical Outreach expanded its reach - bringing not just screening but full medical consultations, prescription support, and pharmacy connections to communities in Lagos. Doctors, nurses, and pharmacists volunteered their time alongside HubPharm's core team, delivering over a day of free care to hundreds of residents.
Afiya is HubPharm's WhatsApp-based AI health assistant - available 24/7 in 50+ languages, providing medication reminders, chronic disease guidance, lifestyle coaching, and mental health support to users across 31 countries. It is free, requires no app download, and escalates to a licensed HubPharm pharmacist when needed.
Afiya's documented 42% adherence improvement makes it one of the most impactful digital health interventions in sub-Saharan Africa today - and a scalable solution that can reach millions more.
23 documented patient and community testimonials across three outreach programmes. These are not case studies - they are real names, real stories, real lives transformed. Click any card to watch.
HubPharm's core pharmacy and chronic care programmes serve patients physically based in Nigeria. But through Afiya AI on WhatsApp and our diaspora medicine delivery programme, we extend health support to Africans wherever in the world they live.
Nigerians in the UK, US, Canada, Europe, and across Africa trust HubPharm to source and deliver authentic medicines to their family members at home - often for conditions that are complex to manage without coordinated specialist pharmacy support.
HubPharm partners with pharmaceutical companies, hospital networks, HMOs, and community organisations to extend our reach and deepen our impact.
The HubPharm Africa 2025 Impact Report details our patient outcomes, programme reach, financial performance, and the clinical evidence behind our 42% adherence improvement. Download it for due diligence, grant applications, or to understand the model.
We publish this report annually in the spirit of full transparency to patients, partners, donors, and the communities we serve.
Key figures from our most recent annual impact assessment covering January-December 2025.
HubPharm Africa is actively seeking seed investment, international grant funding, hospital partnerships, and HMO contracts. If you believe that no patient should die because they cannot access medicine, we want to hear from you.